International organization for the study of inflammatory bowel disease (IOIBD) Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2005
NCT02247258
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now